Loading stock data…
PAHC
$34.03-0.01 (-0.01%)
Market ClosedLast close Jul 24
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Phibro Animal Health Corporation in the Healthcare sector is trading at $34.03 with a market capitalization of $1.3B. Wall Street consensus targets $45.60 (5 analysts), implying a +34.0% move over the next 12 months. The stock is currently 43% below its 52-week high of $60.08, remaining 19.8% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +34.0% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $383.54M↑ | $373.91M↑ | $363.89M↓ | $378.70M↑ | $347.82M |
| Gross Profit | $125.67M↓ | $132.66M↑ | $119.78M↑ | $110.01M↑ | $104.57M |
| Operating Income | $44.65M↓ | $50.33M↓ | $51.26M↑ | $33.72M↑ | $33.52M |
| Net Income | $24.02M↓ | $27.46M↑ | $26.53M↑ | $17.22M↓ | $20.88M |
Peer Comparison
JNJUNHPFE
Fundamentals
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mine...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.29B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.41%
ROE
Elite ROE. Management converts capital into profit efficiently.
26.32%
Volume
Today's trading volume
130,031
Recent News
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is This the Right Time to Hold MYGN Stock in Your Portfolio?
Myriad Genetics expands its testing portfolio and advances its Cancer Care Continuum strategy. Can reimbursement risks and cost pressures temper growth?
3 of Wall Street’s Favorite Stocks with Warning Signs
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
PAHC or LZAGY: Which Is the Better Value Stock Right Now?
PAHC vs. LZAGY: Which Stock Is the Better Value Option?
Phibro Animal Health (PAHC) Leaves Russell Indexes, Is The Stock A Bargain?
Index removal puts Phibro Animal Health in a different spotlight Phibro Animal Health (PAHC) was recently removed from several Russell indices, including the Russell 3000E and Microcap benchmarks. This type of change can alter how certain institutional investors gain exposure to the stock. Index changes like this can trigger adjustments by funds that track or reference those benchmarks. They do not, however, directly affect Phibro Animal Health’s operations, revenue sources, or long history...